MNT To Support Weight Loss: Optimising Semaglutide Therapy Growing scientific evidence supports the use of MNT to improve both the tolerability and the efficacy of semaglutide, thereby optimising clinical outcomes in obesity management [96,97,98,99,100,101,102,103,104,105,106,107]
Who should avoid Sembolic Injection
Research Findings Clinical trials and studies have demonstrated that both Mounjaro and Ozempic/ Wegovy are effective in reducing glucose levels and promoting weight loss
The most basic question whether the drug leads to positive health outcomes in addition, rather than simply weight loss is still somewhat hazy, although early signs are promising, with patients showing improved blood pressure, blood glucose, cholesterol, and various other key health markers
Semaglutides high cost also limits accessibility and many ponder its use for weight loss compared to cheaper options (Kushner et al., 2020)